Literature DB >> 10562689

Cancer of the base of the tongue: past and future.

F Brunin1, V Mosseri, C Jaulerry, D Point, J M Cosset, J Rodriguez.   

Abstract

BACKGROUND: Squamous cell carcinomas of the base of the tongue often are diagnosed at advanced stages, in a context of undernutrition with a history of smoking and alcoholism. The local treatment of these tumours is based on external irradiation, either alone or combined with brachytherapy, followed by salvage surgery in the case of failure. Surgery was rarely performed as first-line treatment in our institution until 1992.
METHODS: From 1960 to 1992, 216 patients were treated, without prior selection, according to the same protocol comprising external irradiation and salvage surgery in the case of failure. The tumour classification (UICC 88) was as follows: 14% of T1, 26% of T2, 44% of T3; 16% of T4; the median age was 58 years; tumour regression was evaluated during and at the end of irradiation.
RESULTS: The locoregional control rates were 45% at 5 years, 37% at 10 years: 82% at 5 and 10 years for stage I, 65% and 54% for stage II, 51% and 45% for stage III, 35% and 32% for stage IV. Overall survival rates were 27% at 5 years and 14% at 10 years; 53% and 27% for stage I, 34% and 17% for stages II and III, 18% and 12% for stage IV. Causes of death were primarily local failures (58%), intercurrent disease (15%), metastases (10%), and second cancers (8%). Multivariate analysis demonstrated three predictive factors of locoregional control and survival: tumour regression at the end of irradiation (p = 0.0001), age (p = 0.04), and tumour stage (p = 0.06).
CONCLUSION: The results of this retrospective series confirm the poor prognosis of tumours of the base of the tongue. Irradiation and surgery remain the standard treatments; possibilities of improvement are currently under evaluation, such as acceleration of irradiation, and concomitant radiochemotherapy combinations, which currently appear to be the most promising approaches. Copyright 1999 John Wiley & Sons, Inc. Head Neck 21: 751-759, 1999.

Entities:  

Mesh:

Year:  1999        PMID: 10562689     DOI: 10.1002/(sici)1097-0347(199912)21:8<751::aid-hed11>3.3.co;2-w

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  10 in total

1.  Oncologic and functional results after transoral laser microsurgery of tongue base carcinoma.

Authors:  Martin Canis; Friedrich Ihler; Hendrik A Wolff; Hans Christiansen; Christoph Matthias; Wolfgang Steiner
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-07-05       Impact factor: 2.503

Review 2.  Robotic surgery for oropharynx cancer: promise, challenges, and future directions.

Authors:  John R de Almeida; Eric M Genden
Journal:  Curr Oncol Rep       Date:  2012-04       Impact factor: 5.075

3.  Mutational analyses of the BRAF, KRAS, and PIK3CA genes in oral squamous cell carcinoma.

Authors:  Karl C Bruckman; Frank Schönleben; Wanglong Qiu; Victoria L Woo; Gloria H Su
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2010-09-01

Review 4.  Novel management of oral cancer: a paradigm of predictive oncology.

Authors:  Jon Sudbø
Journal:  Clin Med Res       Date:  2004-11

5.  Treatment outcomes of external-beam radiotherapy for squamous cell carcinoma of the base of the tongue.

Authors:  Yoshifumi Kawaguchi; Kinji Nishiyama; Takerou Hirata; Kouji Konishi; Shinji Otozai; Motoyuki Suzuki; Tadashi Yoshii; Takashi Fujii; Teruki Teshima
Journal:  Int J Clin Oncol       Date:  2015-03-03       Impact factor: 3.402

6.  Recent advances in managing human papillomavirus-positive oropharyngeal tumors.

Authors:  Giulio Cantu; Stefano Riccio; Sarah Colombo; Madia Pompilio; Paolo Formillo
Journal:  F1000 Med Rep       Date:  2010-03-15

7.  Recurrent genomic alterations in sequential progressive leukoplakia and oral cancer: drivers of oral tumorigenesis?

Authors:  Nilva K Cervigne; Jerry Machado; Rashmi S Goswami; Bekim Sadikovic; Grace Bradley; Bayardo Perez-Ordonez; Natalie Naranjo Galloni; Ralph Gilbert; Patrick Gullane; Jonathan C Irish; Igor Jurisica; Patricia P Reis; Suzanne Kamel-Reid
Journal:  Hum Mol Genet       Date:  2014-01-08       Impact factor: 6.150

8.  Survival and Functional Outcome after Treatment for Primary Base of Tongue Cancer: A Comparison of Definitive Chemoradiotherapy versus Surgery Followed by Adjuvant Radiotherapy.

Authors:  Sangjoon Park; Yeona Cho; Jeongshim Lee; Yoon Woo Koh; Se-Heon Kim; Eun Chang Choi; Hye Ryun Kim; Ki Chang Keum; Kyung Ran Park; Chang Geol Lee
Journal:  Cancer Res Treat       Date:  2017-12-26       Impact factor: 4.679

9.  Monocarboxylate Transporter 4 (MCT4) Knockout Mice Have Attenuated 4NQO Induced Carcinogenesis; A Role for MCT4 in Driving Oral Squamous Cell Cancer.

Authors:  Sara Bisetto; Diana Whitaker-Menezes; Nicole A Wilski; Madalina Tuluc; Joseph Curry; Tingting Zhan; Christopher M Snyder; Ubaldo E Martinez-Outschoorn; Nancy J Philp
Journal:  Front Oncol       Date:  2018-08-28       Impact factor: 6.244

10.  ERK Activation Modulates Cancer Stemness and Motility of a Novel Mouse Oral Squamous Cell Carcinoma Cell Line.

Authors:  Yu-Lin Chen; Ko-Jiunn Liu; Chuan-Wei Jang; Chia-Chun Hsu; Yi-Chen Yen; Yi-Ling Liu; Tsung-Hsien Chuang; Ssu-Han Wang; Yu-Ke Fu; Ching-Chuan Kuo; Ya-Wen Chen
Journal:  Cancers (Basel)       Date:  2019-12-24       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.